-
Open Access Bioinformatics
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
A method for ranking compounds based on their relative toxicity using neural networking, C. elegans, axenic liquid culture, and the COPAS parameters TOF and EXT
Original Research
(1383) Views (388) Full article downloads
Authors: Martine Ferguson, Marc Boyer, Robert Sprando
Published Date October 2010
Volume 2010:2 Pages 139 - 144
DOI: http://dx.doi.org/10.2147/OAB.S13466
Martine Ferguson1, Marc Boyer1, Robert Sprando21United States Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Food Defense Communication and Emergency Response, Division of Public Health and Biostatistics, College Park, MD, USA; 2United States Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Applied Research and Safety Assessment, Division of Toxicology, Laurel, MD, USA
Abstract: Caenorhabditis elegans (L1s) were exposed to (in order of decreasing toxicity) sodium arsenite, sodium fluoride, caffeine, valproic acid, sodium borate, or dimethyl sulfoxide in C. elegans habitation medium (CeHM) for 72 consecutive hours. At this time point nematode growth and development were assessed using a Complex Object Parametric Analyzer and Sorter (COPAS™). The COPAS generated biomarkers of growth (time of flight [TOF] – a measure of axial length) and development (extinction [EXT] – a measure of optical density) were subsequently utilized to rank compounds according to their relative toxicity, as measured by the rat oral LD-50, using artificial neural network methods. Neural network methods were utilized to analyze this data because of their ability to model nonlinear endpoints and a multilayer perceptron neural network method was used because of its capability to function well in the presence of collinearity. Using a neural network approach we found that the LD-50 was correctly predicted 96% of the time. The present study demonstrates that neural network methods can be utilized to rank compounds according to their relative toxicity using COPAS-generated data (TOF and EXT) obtained from exposing a large number of nematodes to water-soluble compounds in axenic liquid culture.
Keywords: neural network, TOF, EXT, COPAS, C. elegans, rat oral LD-50
Readers of this article also read:
Current trends in the treatment of infantile spasms
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
Antigenic epitopes prediction and MHC binder of a paralytic insecticidal toxin (ITX-1) of Tegenaria agrestis (hobo spider)
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
Patient outcome in migraine prophylaxis: the role of psychopharmacological agents
Wearing facemasks when performing lumbar punctures: a snapshot of current practice amongst trainee doctors
Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Evolution of a domain conserved in microtubule-associated proteins of eukaryotes
- Is gene activity in plant cells affected by UMTS-irradiation? A whole genome approach
- Discrimination between biological interfaces and crystal-packing contacts
- A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells




